Get started
Author

R. Matthew Hutchison

Trial of Cinpanemab in Early Parkinson’s Disease
2022 · Anthony E. Lang, Andrew D. Siderowf, et al. · New England Journal of Medicine · 353
PDF
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease
2023 · Amanda L. Edwards, Jessica A. Collins, et al. · JAMA Neurology · 112
Abnormal frontoinsular-default network dynamics in adolescent depression and rumination: a preliminary resting-state co-activation pattern analysis
2019 · Roselinde H. Kaiser, Min Su Kang, et al. · Neuropsychopharmacology · 111
PDF
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker
2021 · Rahul Gaurav, Lydia Yahia‐Cherif, et al. · Movement Disorders · 105
PDF
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
2024 · Antoine Leuzy, Lars Lau Raket, et al. · Alzheimer s & Dementia · 51
Cinpanemab in Early Parkinson Disease
2024 · R. Matthew Hutchison, Kyle Fraser, et al. · Neurology · 44
STAIR X
2018 · David S. Liebeskind, Colin P. Derdeyn, et al. · Stroke · 30
Muting, not fragmentation, of functional brain networks under general anesthesia
2021 · Corson N. Areshenkoff, Joseph Y. Nashed, et al. · NeuroImage · 27
PDF
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson’s disease trial
2021 · R. Matthew Hutchison, Karleyton C. Evans, et al. · BMC Neurology · 20
PDF
Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences
2021 · Amgad Droby, Avner Thaler, et al. · PLoS ONE · 18
Dynamic Reconfiguration, Fragmentation, and Integration of Whole-Brain Modular Structure across Depths of Unconsciousness
2020 · Dominic Standage, Corson N Areshenkoff, et al. · Cerebral Cortex · 18
PDF
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
2022 · Amgad Droby, Moran Artzi, et al. · npj Parkinson s Disease · 11
PDF
Post‐stroke blood–brain barrier disruption predicts poor outcome in patients enrolled in the ACTION study
2021 · Richard Leigh, Emi Hitomi, et al. · Journal of Neuroimaging · 11
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer's Disease
2024 · Tianle Chen, R.M. Hutchison, et al. · The Journal of Prevention of Alzheimer s Disease · 10
Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease
2024 · Yasuo Toda, T. Iwatsubo, et al. · The Journal of Prevention of Alzheimer s Disease · 10
Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity
2018 · Brian B. Avants, R. Matthew Hutchison, et al. · Neurobiology of Aging · 10
Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease
2025 · Jackson Burton, Holly M. Brothers, et al. · The Journal of Prevention of Alzheimer s Disease · 8
Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer’s disease
2026 · Lindsay A. Welikovitch, Derek H. Oakley, et al. · Acta Neuropathologica · 3
PDF
A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer’s disease
2026 · Tianle Chen, R. Matthew Hutchison, et al. · The Journal of Prevention of Alzheimer s Disease · 2
Harmonization of tau‐PET in Alzheimer’s disease: comparison of methods to derive CenTauR units for [18F]RO948, [18F]Flortaucipir, and [18F]MK‐6240
2023 · Antoine Leuzy, Vincent Dore, et al. · Alzheimer s & Dementia · 2
PDF
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
2025 · Alexis Moscoso, Antoine Leuzy, et al. · Alzheimer s & Dementia · 1
PDF
Harmonization of tau‐PET in Alzheimer’s disease: comparison of methods to derive CenTauR units for [18F]RO948, [18F]Flortaucipir, and [18F]MK‐6240
2023 · Antoine Leuzy, Vincent Dore, et al. · Alzheimer s & Dementia · 1
PDF
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
2025 · Alexis Moscoso, Antoine Leuzy, et al. · Alzheimer s & Dementia
PDF
Baseline characteristics from CELIA: A Phase 2 study to evaluate BIIB080 in participants with Early Alzheimer’s Disease
2025 · Melanie Shulman, Shuang Wu, et al. · Alzheimer s & Dementia
PDF
Use of Multimodal Imaging in a Phase 2 Study in Participants with Parkinson’s Disease (SPARK) (1516)
2020 · R. Matthew Hutchison, Karleyton C. Evans, et al. · Neurology
Works count: 25
Citation count: 958
H-index: 11
I10-index: 16
Year
Topic
Type